Inogen, Inc. ( INGN) - Key Metrics
INGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.01 | -$0.26 | -$0.03 | -$0.11 |
| 2025Q3 | $3.50 | -$0.20 | $0.08 | $0 |
| 2025Q2 | $3.42 | -$0.15 | $0.16 | $0.02 |
| 2025Q1 | $3.27 | -$0.25 | -$0.67 | -$0.75 |
INGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.41 |
| 2025Q3 | ? | -10.19 |
| 2025Q2 | ? | -11.41 |
| 2025Q1 | ? | -7.27 |
INGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -4.42% | ? |
| 2025Q4 | -1.82% | ? |
| 2025Q3 | 0.03% | ? |
| 2025Q2 | 0.25% | ? |
| 2025Q1 | -10.49% | ? |
INGN
Price: $6.41
52 week price:
Earnings Per Share: -0.91 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 86424
Ebitda: 11.8 millionMarket Capitalization: 175.8 million